Ian Wakefield

524 total citations
7 papers, 259 citations indexed

About

Ian Wakefield is a scholar working on Cardiology and Cardiovascular Medicine, Pediatrics, Perinatology and Child Health and Immunology. According to data from OpenAlex, Ian Wakefield has authored 7 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Immunology. Recurrent topics in Ian Wakefield's work include Cardiac electrophysiology and arrhythmias (3 papers), Pharmaceutical studies and practices (3 papers) and Biosimilars and Bioanalytical Methods (2 papers). Ian Wakefield is often cited by papers focused on Cardiac electrophysiology and arrhythmias (3 papers), Pharmaceutical studies and practices (3 papers) and Biosimilars and Bioanalytical Methods (2 papers). Ian Wakefield collaborates with scholars based in United Kingdom, Switzerland and Germany. Ian Wakefield's co-authors include Jean‐Pierre Valentin, Chris Pollard, Najah Abi‐Gerges, Tim Hammond, William S. Redfern, Timothy G. Hammond, Helen Prior, Christopher E. Pollard, Jean‐Pierre Valentin and Sheila M. Gardiner and has published in prestigious journals such as British Journal of Pharmacology, Drug Discovery Today and Toxicological Sciences.

In The Last Decade

Ian Wakefield

7 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian Wakefield United Kingdom 6 140 99 30 29 24 7 259
J Colina-Chourio Venezuela 8 103 0.7× 89 0.9× 10 0.3× 12 0.4× 38 1.6× 16 381
R Haasis Germany 10 144 1.0× 38 0.4× 22 0.7× 27 0.9× 18 0.8× 36 425
Rujia Miao China 10 73 0.5× 116 1.2× 33 1.1× 23 0.8× 34 1.4× 17 300
Serge Renaud France 12 56 0.4× 46 0.5× 12 0.4× 35 1.2× 44 1.8× 17 294
Tetsuya Kitayama Japan 10 195 1.4× 159 1.6× 7 0.2× 3 0.1× 5 0.2× 17 342
Adebayo Oluwafemi Adekunle China 11 87 0.6× 85 0.9× 27 0.9× 20 0.7× 22 0.9× 18 308
Alberto B. Alonso United States 10 88 0.6× 78 0.8× 18 0.6× 18 0.6× 25 1.0× 14 306
Ünal Güntekin Türkiye 13 307 2.2× 41 0.4× 18 0.6× 9 0.3× 32 1.3× 50 436
Régis Périchon United States 10 92 0.7× 193 1.9× 13 0.4× 43 1.5× 97 4.0× 11 422
Absalon Gutierrez United States 10 41 0.3× 141 1.4× 18 0.6× 9 0.3× 66 2.8× 18 430

Countries citing papers authored by Ian Wakefield

Since Specialization
Citations

This map shows the geographic impact of Ian Wakefield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Wakefield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Wakefield more than expected).

Fields of papers citing papers by Ian Wakefield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Wakefield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Wakefield. The network helps show where Ian Wakefield may publish in the future.

Co-authorship network of co-authors of Ian Wakefield

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Wakefield. A scholar is included among the top collaborators of Ian Wakefield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Wakefield. Ian Wakefield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Kronenberg, Sven, Andreas Baumann, Lolke de Haan, et al.. (2013). Current challenges and opportunities in nonclinical safety testing of biologics. Drug Discovery Today. 18(23-24). 1138–1143. 18 indexed citations
2.
Wakefield, Ian, Sue Stephens, Roly Foulkes, Andrew Nesbitt, & Tim Bourne. (2011). The Use of Surrogate Antibodies to Evaluate the Developmental and Reproductive Toxicity Potential of an Anti-TNFα PEGylated Fab′ Monoclonal Antibody. Toxicological Sciences. 122(1). 170–176. 24 indexed citations
3.
Abi‐Gerges, Najah, et al.. (2004). Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes. Fundamental and Clinical Pharmacology. 18(2). 139–151. 103 indexed citations
4.
Wakefield, Ian, J E March, Philip A. Kemp, et al.. (2003). Comparative regional haemodynamic effects of the nitric oxide synthase inhibitors, S‐methyl‐L‐thiocitrulline and L‐NAME, in conscious rats. British Journal of Pharmacology. 139(6). 1235–1243. 31 indexed citations
5.
Wakefield, Ian, Chris Pollard, William S. Redfern, Timothy G. Hammond, & Jean‐Pierre Valentin. (2002). The application of in vitro methods to safety pharmacology. Fundamental and Clinical Pharmacology. 16(3). 209–218. 33 indexed citations
6.
Redfern, William S., Ian Wakefield, Helen Prior, et al.. (2002). Safety pharmacology – a progressive approach. Fundamental and Clinical Pharmacology. 16(3). 161–173. 48 indexed citations
7.
Kerry, P J, Ian Wakefield, & J.G. Evans. (1993). Ocular Changes Induced in the Beagle Dog by Intravenous Infusion of a Novel Dopaminergic Compound, FPL 65447. Toxicologic Pathology. 21(3). 274–282. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026